These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 28195831)
1. Psychometric Properties of the Turkish Versions of the Cannabis Use Problems Identification Test (CUPIT) and the Adult Cannabis Problems Questionnaire (CPQ). Evren C; Yilmaz Cengel H; Bozkurt M; Evren B; Umut G; Agachanli R J Psychoactive Drugs; 2017; 49(1):83-89. PubMed ID: 28195831 [TBL] [Abstract][Full Text] [Related]
2. The Cannabis Use Problems Identification Test (CUPIT): development, reliability, concurrent and predictive validity among adolescents and adults. Bashford J; Flett R; Copeland J Addiction; 2010 Apr; 105(4):615-25. PubMed ID: 20403014 [TBL] [Abstract][Full Text] [Related]
3. Psychometric properties of the Spanish version of the Cannabis Use Problems Identification Test among Chilean university students: A validation study. Cantillano V; Del Villar P; Contreras L; Martínez D; Zuzulich MS; Ramírez C; Pons C; Bashford J Drug Alcohol Depend; 2017 Jan; 170():32-36. PubMed ID: 27866060 [TBL] [Abstract][Full Text] [Related]
4. The Adolescent Cannabis Problems Questionnaire (CPQ-A): psychometric properties. Martin G; Copeland J; Gilmour S; Gates P; Swift W Addict Behav; 2006 Dec; 31(12):2238-48. PubMed ID: 16626880 [TBL] [Abstract][Full Text] [Related]
5. [Spanish adaptation and validation of The Adolescent-Cannabis Problems Questionnaire (CPQ-A)]. Fernández-Artamendi S; Fernández-Hermida JR; García-Cueto E; Secades-Villa R; García-Fernández G; Barrial-Barbén S Adicciones; 2012; 24(1):41-9. PubMed ID: 22508016 [TBL] [Abstract][Full Text] [Related]
6. Screening of cannabis-related problems among youth: the CPQ-A-S and CAST questionnaires. Fernandez-Artamendi S; Fernández-Hermida JR; Muñiz-Fernández J; Secades-Villa R; García-Fernández G Subst Abuse Treat Prev Policy; 2012 Apr; 7():13. PubMed ID: 22471908 [TBL] [Abstract][Full Text] [Related]
7. Measuring cannabis consumption: Psychometric properties of the Daily Sessions, Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU). Cuttler C; Spradlin A PLoS One; 2017; 12(5):e0178194. PubMed ID: 28552942 [TBL] [Abstract][Full Text] [Related]
8. The Cannabis Problems Questionnaire: factor structure, reliability, and validity. Copeland J; Gilmour S; Gates P; Swift W Drug Alcohol Depend; 2005 Dec; 80(3):313-9. PubMed ID: 15916867 [TBL] [Abstract][Full Text] [Related]
9. Development and Validation of Cannabis Use Disorder Scale among University Undergraduates in Nigeria. Owoeye OA; Aina OF; Makanju O; Aroyewun AB West Afr J Med; 2023 Oct; 40(10):1107-1117. PubMed ID: 37906961 [TBL] [Abstract][Full Text] [Related]
10. Psychometric assessment of the marijuana adolescent problem inventory. Knapp AA; Babbin SF; Budney AJ; Walker DD; Stephens RS; Scherer EA; Stanger C Addict Behav; 2018 Apr; 79():113-119. PubMed ID: 29288984 [TBL] [Abstract][Full Text] [Related]
11. Synthetic cannabinoid withdrawal: a new demand on detoxification services. Macfarlane V; Christie G Drug Alcohol Rev; 2015 Mar; 34(2):147-53. PubMed ID: 25588420 [TBL] [Abstract][Full Text] [Related]
12. Psychometric properties of the Turkish versions of the Drug Use Disorders Identification Test (DUDIT) and the Drug Abuse Screening Test (DAST-10) in the prison setting. Evren C; Ogel K; Evren B; Bozkurt M J Psychoactive Drugs; 2014; 46(2):140-6. PubMed ID: 25052790 [TBL] [Abstract][Full Text] [Related]
13. Cannabis withdrawal syndrome: An important diagnostic consideration in adolescents presenting with disordered eating. Chesney T; Matsos L; Couturier J; Johnson N Int J Eat Disord; 2014 Mar; 47(2):219-23. PubMed ID: 24281745 [TBL] [Abstract][Full Text] [Related]
14. A prospective observational study of problematic oral cannabinoid use. Ware MA; Martel MO; Jovey R; Lynch ME; Singer J Psychopharmacology (Berl); 2018 Feb; 235(2):409-417. PubMed ID: 29250737 [TBL] [Abstract][Full Text] [Related]
15. Development of a short cannabis problems questionnaire for adolescents in the community. Proudfoot H; Vogl L; Swift W; Martin G; Copeland J Addict Behav; 2010 Jul; 35(7):734-7. PubMed ID: 20356683 [TBL] [Abstract][Full Text] [Related]
16. Validation of the Cannabis Abuse Screening Test in a sample of cannabis inpatients. Legleye S; Kraus L; Piontek D; Phan O; Jouanne C Eur Addict Res; 2012; 18(4):193-200. PubMed ID: 22472963 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the psychometric properties of the cannabis use disorders identification test - revised among college students. Schultz NR; Bassett DT; Messina BG; Correia CJ Addict Behav; 2019 Aug; 95():11-15. PubMed ID: 30798191 [TBL] [Abstract][Full Text] [Related]
18. The Cannabis Withdrawal Scale development: patterns and predictors of cannabis withdrawal and distress. Allsop DJ; Norberg MM; Copeland J; Fu S; Budney AJ Drug Alcohol Depend; 2011 Dec; 119(1-2):123-9. PubMed ID: 21724338 [TBL] [Abstract][Full Text] [Related]
19. Psychometric properties of the Drug Use Disorders Identification Test (DUDIT) with substance abusers in outpatient and residential treatment. Voluse AC; Gioia CJ; Sobell LC; Dum M; Sobell MB; Simco ER Addict Behav; 2012 Jan; 37(1):36-41. PubMed ID: 21937169 [TBL] [Abstract][Full Text] [Related]
20. Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis. Mensen VT; Vreeker A; Nordgren J; Atkinson A; de la Torre R; Farré M; Ramaekers JG; Brunt TM Psychopharmacology (Berl); 2019 Sep; 236(9):2677-2685. PubMed ID: 30968175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]